Streetbeat News

Earnings

TEVA

Teva Pharmaceutical Indus (NYSE:TEVA) reported Q3 earnings of $0.60 per share, missing the analyst consensus estimate of $0.61 by 1.64%. However, the company's quarterly sales of $3.85 billion beat the analyst consensus estimate of $3.72 billion by 3.49%. This represents a 7.09% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:06 pm

CIFR

Cipher Mining (NASDAQ:CIFR) reported Q3 earnings of $0.02 per share, beating the analyst consensus estimate of $(0.04) by 150 percent. However, the company's quarterly sales of $30.30 million missed the analyst consensus estimate of $36.74 million by 17.52 percent.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:06 pm

WBD

Warner Bros. Discovery reported Q3 2023 earnings per share (EPS) of $(0.17), missing the estimate of $(0.06). The company's revenue was $9.979M, falling short of the $10B estimate.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:06 pm

CSTE

Caesarstone reported Q3 adjusted losses of $(0.20) per share, missing the analyst consensus estimate of $(0.16) by 25%. This is a 2100% decrease from last year's earnings. The company also reported quarterly sales of $142.20 million, missing the analyst consensus estimate of $153.43 million by 7.32%. This is a 21.32% decrease from last year's sales.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:05 pm

SHOO

Steven Madden (NASDAQ:SHOO) reported Q3 adjusted earnings of $0.88 per share, beating the analyst consensus estimate of $0.86 by 2.33%. This is an 11.39% increase from the same period last year. The company also reported quarterly sales of $552.73 million, beating the analyst consensus estimate of $549.32 million by 0.62%, but a 0.70% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:05 pm

PFGC

Performance Food Gr (NYSE:PFGC) reported Q1 adjusted earnings of $1.15 per share, beating the analyst consensus estimate of $1.09 by 5.5%. This is a 6.48% increase from the same period last year. However, the company's quarterly sales of $14.94 billion missed the analyst consensus estimate of $14.95 billion by 0.07%. This is a 1.49% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:05 pm

BIIB

Biogen has revised its FY23 adjusted EPS guidance to $14.50-$15.00, down from the previous guidance of $15.00-$16.00. This is also below the consensus estimate of $15.23.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:04 pm

NYT

New York Times (NYSE:NYT) reported Q3 earnings of $0.37 per share, beating the analyst consensus estimate of $0.29 by 27.59%. This is a 76.19% increase from the same period last year. The company also reported quarterly sales of $598.35 million, beating the analyst consensus estimate of $589.40 million by 1.52%. This is a 9.25% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:04 pm

REYN

Reynolds Consumer Prods (NASDAQ:REYN) reported Q3 adjusted earnings of $0.37 per share, in line with analyst consensus. This is a 54.17% increase from the same period last year. The company's quarterly sales of $935.00 million beat the analyst consensus estimate of $932.44 million by 0.27%, but it's a 3.31% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:04 pm

VFF

Village Farms Intl (NASDAQ:VFF) reported Q3 losses of $(0.01) per share, beating the analyst consensus estimate of $(0.04) by 75 percent. However, the company's quarterly sales of $69.50 million missed the analyst consensus estimate of $70.83 million by 1.88 percent.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 12:04 pm